U.S. Markets open in 18 mins

Stocks - GE Soars in Premarket, Newmont Mining, Spring Rise, Kraft Falls

Investing.com - Stocks in focus in premarket trade Monday:

• General Electric (NYSE:GE) stock rocketed 17.80% by 8:12 AM ET (13:12 GMT) after the company agreed to sell its BioPharma business to Danaher (NYSE:DHR) for $21.4 billion.

• Kraft Heinz (NASDAQ:KHC) stock fell 0.92%, unable to manage even a dead-cat bounce after Friday's slump after Warren Buffett wrote billions off the value of Berkshire Hathaway (NYSE:BRKa)'s stake. While Buffett plans on holding the stake, he will not add to it. Separately, CNBC reported that the company hired Credit Suisse (SIX:CSGN) to study strategic options for its Maxwell House coffee business.

• Spark Therapeutics (NASDAQ:ONCE) stock surged 120.91% after Roche said it will acquire the company for $114.50 a share, or approximately $4.3 billion.

• Newmont Mining (NYSE:NEM) stock rose 1.32% as Barrick Gold offered to acquire the company in an all-stock merger. Barrick's offer doesn't envisage any premium for Newmont stock.

• Caesars Entertainment (NASDAQ:CZR) stock advanced 2.43% as the company prepares to offer activist investor Carl Icahn a role in selecting its next chief executive, according to people familiar with the matter cited by Reuters.

• Twitter (NYSE:TWTR) stock traded up 0.69% after a company announcement that co-founder and former chief executive Evan Williams (NYSE:WMB) plans to step down from its board of directors at the end of the month.

• Sprint (NYSE:S) stock gained 1.40% as the company announced that it would launch commercial 5G beginning in May.

• Avon Products (NYSE:AVP) stock jumped 5.30% as the company announced the launch of a new content studio to drive digital growth.

• Qualcomm (NASDAQ:QCOM) stock rose 1.51% as the company announced a launch of 5G chips for cars, PCS and home broadband in an attempt to move beyond the smartphone market.

• Marathon Oil (NYSE:MRO) stock lost 0.83% as the company announced an agreement to sell its assets in the North Sea to RockRose Energy for approximately $140 million.

• Clementia Pharmaceuticals (NASDAQ:CMTA) stock soared 71.75% after Ipsen agreed to buy the company in a deal worth approximately $1.31 billion.

Related Articles

JD.com shares jump on upbeat sales performance

Uber, Lyft to offer drivers shares in stock market listing: WSJ

J.C. Penney beats same-store sales forecasts, shares surge 20 percent